Resources Investment Advisors, Llc. Karuna Therapeutics, Inc. Transaction History

Resources Investment Advisors, Llc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $178,721 - $352,813	1,110 New	1,110 $351,000
Q2 2023 Aug 07, 2023	BUY	$176.32 - $240.22 $179,141 - $244,063	1,016 New	1,016 $220,000
Q3 2022 Nov 08, 2022	SELL	$123.79 - $277.42 $3.3 Million - $7.39 Million	-26,650 Reduced 96.34%	1,013 $228,000
Q2 2022 Aug 08, 2022	BUY	$93.97 - $143.33 $56,382 - $85,998	600 Added 2.22%	27,663 $3.5 Million
Q2 2021 Aug 09, 2021	SELL	$107.45 - $135.95 $2.15 Million - $2.72 Million	-20,000 Reduced 42.5%	27,063 $3.08 Million
Q1 2021 May 10, 2021	SELL	$95.46 - $133.08 $720,627 - $1 Million	-7,549 Reduced 13.82%	47,063 $5.66 Million
Q4 2020 Feb 08, 2021	SELL	$75.23 - $109.23 $127,138 - $184,598	-1,690 Reduced 3.0%	54,612 $5.55 Million
Q3 2020 Oct 09, 2020	SELL	$71.31 - $109.74 $1.42 Million - $2.19 Million	-19,982 Reduced 26.19%	56,302 $4.35 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $4.74 Million - $8.94 Million	76,284 New	76,284 $8.5 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.